Sign in

NCT05165654Completed

Improving Hallucinations by Targeting the rSTS With tES

Improving Hallucinations by Targeting the Right Superior Temporal Sulcus With Electrical Stimulation

Source: ClinicalTrials.gov · Last updated 17 Sept 2025

Brief summary (registry, in English)

Hallucinations are a core diagnostic feature of psychotic disorders. They involve different sensory modalities, including auditory, visual, olfactory, tactile, and gustatory hallucinations, among others. Hallucinations occur in multiple different neurological and psychiatric illnesses and can be refractory to existing treatments. Auditory hallucinations and visual hallucinations are found across diagnostic categories of psychotic disorders (schizophrenia, schizoaffective, bipolar disorder). Despite visual hallucinations being approximately half as frequent as auditory hallucinations, they almost always co-occur with auditory hallucinations, and are linked to a more severe psychopathological profile. Auditory and visual hallucinations at baseline also predict higher disability, risk of relapse and duration of psychosis after 1 and 2 years, especially when they occur in combination. Using a newly validated technique termed lesion network mapping, researchers demonstrated that focal brain lesions connected to the right superior temporal sulcus (rSTS) plays a causal role in the development of hallucinations. The rSTS receives convergent somatosensory, auditory, and visual inputs, and is regarded as a site for multimodal sensory integration. Here the investigators aim to answer the question whether noninvasive brain stimulation when optimally targeted to the rSTS can improve brain activity, sensory integration, and hallucinations.

Status (registry)
Completed
Study type
Interventional
Enrollment
12 (actual)
First submitted
17 Nov 2021
Start date
1 Nov 2021
Primary completion date
1 Jun 2025
Lead sponsor
Beth Israel Deaconess Medical Center
NCT number
NCT05165654

What you commit to

  • Study type: Interventional
  • Participants enrolled: 12
  • From 1 Nov 2021 to the primary completion date, 1 Jun 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • History of head injury with \> 15 minutes of loss of consciousness/mal sequelae
  • History of seizures

Other

  • Substance abuse or dependence (w/in past 6 months)
  • Those who are pregnant/breastfeeding
  • DSM-V intellectual disability
  • Having a non-removable ferromagnetic metal within the body (particularly in the head)

Who the study is looking for

  • Aged 18-50 years of age
  • Proficient in English
  • Able to give informed consent
  • Actively experiencing hallucinations (tactile, auditory, visual, etc.)
  • Has not recently participated in tES/TMS treatments

Age in the registry: 18 years to 50 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Beth Israel Deaconess Medical Center
Coordinator of this site? Confirm its status
BostonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.